Sabby Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-12,493
Closed -$12.1M 183
2017
Q2
$12.1M Buy
12,493
+733
+6% +$4.76K 0.79% 21
2017
Q1
$7M Buy
11,760
+9,781
+494% +$47K 0.38% 35
2016
Q4
$782K Sell
1,979
-8,005
-80% -$58.6K 0.05% 162
2016
Q3
$10.5M Sell
9,984
-728
-7% -$10.5K 0.39% 45
2016
Q2
$15.6M Buy
10,712
+9,412
+724% +$161K 0.81% 23
2016
Q1
$2.5M Sell
1,300
-607
-32% -$12.3K 0.13% 83
2015
Q4
$4.61M Sell
1,907
-166
-8% -$4.16K 0.25% 65
2015
Q3
$5.09M Sell
2,073
-2,460
-54% -$69.7K 0.21% 81
2015
Q2
$10.6M Buy
+4,533
New +$98.7K 0.39% 52

Other funds holding DVAX

Sabby Management's DVAX Position: Q1 2017 in Review

Sabby Management sold out of Dynavax Technologies (DVAX) in Q1 2017, closing a stake of 66,091 shares — an estimated $318K sold.

Sabby Management first reported a position in DVAX in Q4 2013 and held it in 8 quarters. The position peaked at $5.47M in Q3 2016. 101 funds tracked by Wall St. Rank hold DVAX as of Q1 2017.

  • Sabby Management reported no remaining Dynavax Technologies position as of Q1 2017 after selling out during the quarter.
  • Sabby Management sold 66,091 Dynavax Technologies shares in Q1 2017, an estimated $318K.
  • Sabby Management first reported a position in Dynavax Technologies in Q4 2013 and held it in 8 quarters.
  • Sabby Management's Dynavax Technologies position peaked at $5.47M in Q3 2016.
  • 101 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2017.

Based on Sabby Management's 13F filing for Q1 2017, filed 15 May 2017.